Screening for retinopathy of prematurity in China: a five-year cohort study in seven screening centers

Yusheng Zhong1, Xiacheng Lin1, Yating Yang1

  • 1Department of Ophthalmology, Peking University People's Hospital, Beijing Key Laboratory of Ocular Disease and Optometry Science, Beijing, China.

BMC Ophthalmology
|January 3, 2025
PubMed

Insights

Optimized screening for retinopathy of prematurity (ROP) in China suggests new guidelines. Lowering gestational age (GA) and birth weight (BW) criteria can reduce screening while maintaining high detection rates for ROP.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Public Health

Background:

  • Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
  • Current ROP screening guidelines in China may not reflect recent demographic shifts in premature infants.

Purpose of the Study:

  • To analyze the demographic characteristics of infants diagnosed with ROP in China.
  • To propose optimized screening criteria for ROP to improve guideline efficiency.

Main Methods:

  • A multicenter, retrospective-cohort study involving 4770 infants diagnosed with ROP.
  • Analysis of gestational age (GA) and birth weight (BW) data from infants screened between 2018 and 2023.
  • Utilized receiver operating characteristic (ROC) curves to determine optimal predictive models for ROP screening.

Main Results:

  • The study identified a mean GA of 29.67 weeks and mean BW of 1295.89 g among ROP infants.
  • Proposed optimized screening criteria of GA ≤ 30 weeks and BW ≤ 1600 g.
  • The optimized criteria achieved 99.4% sensitivity with an 18.0% reduction in screening requirements.

Conclusions:

  • The demographic characteristics of infants requiring ROP treatment in China have shifted.
  • Updating ROP screening guidelines with lower GA and BW thresholds is recommended.
  • Optimized guidelines can enhance screening efficiency without compromising detection rates.
Abstract